SEC Form 4 · accession 0001179110-18-010174
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Clive Meanwell
Officer — CEO · Director
Period of report
Aug 1, 2018
Accepted (ET)
Aug 2, 2018 · 5:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Aug 1, 2018 | S | 50,000 | $39.24 | D | 352,034 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sales were effected pursuant to a Rule 10b-5 program adopted by Dr. Meanwell.
- F2Represents the weighted average sales price of the shares sold ranging from a low of $38.05 to a high of $39.98 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.